Charleston - Huntington, West Virginia -- WOWK -- 13NewsFDA approves new suppliers for two crucial cancer drugs recently in short supply

FDA approves new suppliers for two crucial cancer drugs recently in short supply

Posted: Updated:
By April Kaull, Anchor - bio | email

The Food and Drug Administration has approved new suppliers for two crucial cancer drugs that have recently been in short supply. 

The FDA announced Tuesday it will allow a replacement for the drug Doxil to be imported.  

Doxil, which is used to treat ovarian and other cancers, hasn't been available in the United States for months.

The agency also announced the approval of another supplier for the drug Methotrexate, a drug used to teat children with a type of leukemia called ALL.